The abstracts from the Late Breaking Clinical Trials session of the HFSA 20th Annual Scientific Sessions are now available. Please contact [email protected] if you are interested. They will also be published in the November issue of the Journal of Cardiac Failure.

The session took place on  Sunday, September 18, 2016 , from 4:00 pm – 5:30 pm.  Please see below for full listing of schedule.

Moderators: Inder Anand, Minneapolis, MN Ileana Pina, Bronx, NY

Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized With Heart Failure: Results of SECRET of CHF
 Marvin Konstam, Boston, MA
Commentary
Mona Fiuzat, Durham, NC

The Targeting Acute Congestion with Tolvaptan in Congestive Heart Failure Study: A Randomized, Double blind, Placebo-controlled Trial in Acute Heart Failure
Robert Mentz, Durham, NC
Commentary
Clyde Yancy, Chicago, IL

PRIMA II: Can NT-proBNP-guided therapy during hospital admission for acute decompensated heart failure reduce mortality and readmissions? An international, multicenter, randomized clinical trial.
Susan Stienen, Amsterdam, Netherlands
Commentary
Ileana Pina, Bronx, NY

Hemodynamic Monitoring in Advanced Heart Failure: Results from the LAPTOP-HF Trial
William Abraham, Columbus, OH
Commentary
Mark Drazner, Dallas, TX

A Randomized Controlled Trial of a Social Worker-Aided Palliative Care Intervention in High Risk Patients with Heart Failure (SWAP-HF) 
Akshay Desai, Boston, MA
Commentary
Larry Allen, Denver, CO

Palliative Care in Heart Failure: Results of a Randomized, Controlled Clinical Trial
Joseph Rogers, Durham, NC
Commentary
Sarah Goodlin, Portland, OR